Current clinical management of dysfunctional bioprosthetic pulmonary valves

References

• Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000;356(9234):975–981.
   PubMed Web of Science ®Google Scholar
• Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease) developed in collaboration with the American society of echocardiography, heart rhythm society, international society for adult congenital heart disease, society for cardiovascular angiography and interventions, and society of thoracic surgeons. J Am Coll Cardiol. 2008;52(23):e143–e263.
   PubMed Web of Science ®Google Scholar
• Yuan SM, Mishaly D, Shinfeld A, et al. Right ventricular outflow tract reconstruction: valved conduit of choice and clinical outcomes. J Cardiovasc Med (Hagerstown). 2008;9(4):327–337.
   PubMed Web of Science ®Google Scholar
• Skoglund K, Svensson G, Thilén U, et al. Long-term outcome after right ventricle to pulmonary artery conduit surgery and reintervention. Scand Cardiovasc J. 2017;51(5):284–291.
   PubMed Web of Science ®Google Scholar
• Hufnagel CA, Villegas PD, Nahas H. Experiences with new types of aortic valvular prostheses. Ann Surg. 1958;147(5):636–644. discussion 44–5.
   PubMed Web of Science ®Google Scholar
• Ross DN. Evolution of the homograft valve. Ann Thorac Surg. 1995;59(3):565–567.
   PubMed Web of Science ®Google Scholar
• Binet JP. Pioneering in heterografts. Ann Thorac Surg. 1989;48(3 Suppl):S71–2.
   PubMed Web of Science ®Google Scholar
• Carpentier A. The concept of bioprosthesis. Thoraxchir Vask Chir. 1971;19(5):379–383.
   PubMedGoogle Scholar
• Carpentier A. From valvular xenograft to valvular bioprosthesis: 1965–1970. Ann Thorac Surg. 1989;48(3 Suppl):S73–4.
   PubMed Web of Science ®Google Scholar
• Manji RA, Lee W, Cooper DKC. Xenograft bioprosthetic heart valves: past, present and future. Int J Surg. 2015;23(Pt B):280–284.
   PubMedGoogle Scholar
• Li KYC. Bioprosthetic heart valves: upgrading a 50-year old technology. Front Cardiovasc Med. 2019;6:47.
   PubMed Web of Science ®Google Scholar
• Ionescu MI, Tandon AP, Mary DA, et al. Heart valve replacement with the Lonescu-Shiley pericardial xenograft. J Thorac Cardiovasc Surg. 1977;73(1):31–42.
   PubMed Web of Science ®Google Scholar
• Ott DA, Coelho AT, Cooley DA, et al. Lonescu-Shiley pericardial xenograft valve: hemodynamic evaluation and early clinical follow-up of 326 patients. Cardiovasc Dis. 1980;7(2):137–148.
   PubMedGoogle Scholar
• Jones M, Eidbo EE, Hilbert SL, et al. Anticalcification treatments of bioprosthetic heart valves: in vivo studies in sheep. J Card Surg. 1989;4(1):69–73.
   PubMedGoogle Scholar
• Egbe AC, Connolly HM, Miranda WR, et al. Outcomes of bioprosthetic valves in the pulmonary position in adults with congenital heart disease. Ann Thorac Surg. 2019;108:1410–1415.
   PubMed Web of Science ®Google Scholar
• Nomoto R, Sleeper LA, Borisuk MJ, et al. Outcome and performance of bioprosthetic pulmonary valve replacement in patients with congenital heart disease. J Thorac Cardiovasc Surg. 2016;152(5):1333–42.e3.
   PubMed Web of Science ®Google Scholar
• Lee C, Park CS, Lee CH, et al. Durability of bioprosthetic valves in the pulmonary position: long-term follow-up of 181 implants in patients with congenital heart disease. J Thorac Cardiovasc Surg. 2011;142(2):351–358.
   PubMed Web of Science ®Google Scholar
• Shinkawa T, Lu CK, Chipman C, et al. The midterm outcomes of bioprosthetic pulmonary valve replacement in children. Semin Thorac Cardiovasc Surg. 2015;27(3):310–318.
   PubMed Web of Science ®Google Scholar
• McKenzie ED, Khan MS, Dietzman TW, et al. Surgical pulmonary valve replacement: a benchmark for outcomes comparisons. J Thorac Cardiovasc Surg. 2014;148(4):1450–1453.
   PubMed Web of Science ®Google Scholar
• Davlouros PA, Karatza AA, Gatzoulis MA, et al. Timing and type of surgery for severe pulmonary regurgitation after repair of tetralogy of Fallot. Int J Cardiol. 2004;97(Suppl 1):91–101.
   PubMedGoogle Scholar
• Geva T. Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support. J Cardiovasc Magn Reson. 2011;13:9.
   PubMed Web of Science ®Google Scholar
• Pragt H, Schoots MH, Accord RE, et al. A stented bovine pericardial prosthesis in the pulmonary position. J Thorac Cardiovasc Surg. 2019. pii: S0022-5223(19)31355-8. Epub ahead of print.
   Google Scholar
• Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2019;139(14):e637–e97.
   PubMed Web of Science ®Google Scholar
• Karamlou T, Blackstone EH, Hawkins JA, et al. Can pulmonary conduit dysfunction and failure be reduced in infants and children less than age 2 years at initial implantation? J Thorac Cardiovasc Surg. 2006;132(4):829–838.
   PubMed Web of Science ®Google Scholar
• Dearani JA, Danielson GK, Puga FJ, et al. Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. Ann Thorac Surg. 2003;75(2):399–410. discussion −1.
   PubMed Web of Science ®Google Scholar
• Bapat VN, Attia R, Thomas M. Effect of valve design on the stent internal diameter of a bioprosthetic valve: a concept of true internal diameter and its implications for the valve-in-valve procedure. JACC Cardiovasc Interv. 2014;7(2):115–127.
   PubMed Web of Science ®Google Scholar
• Batlivala SP, Emani S, Mayer JE, et al. Pulmonary valve replacement function in adolescents: a comparison of bioprosthetic valves and homograft conduits. Ann Thorac Surg. 2012;93(6):2007–2016.
   PubMed Web of Science ®Google Scholar
• Chen XJ, Smith PB, Jaggers J, et al. Bioprosthetic pulmonary valve replacement: contemporary analysis of a large, single-center series of 170 cases. J Thorac Cardiovasc Surg. 2013;146(6):1461–1466.
   PubMed Web of Science ®Google Scholar
• Dittrich S, Alexi-Meskishvili VV, Yankah AC, et al. Comparison of porcine xenografts and homografts for pulmonary valve replacement in children. Ann Thorac Surg. 2000;70(3):717–722.
   PubMed Web of Science ®Google Scholar
• Mitchell MB. Pulmonary valve replacement for congenital heart disease: what valve substitute should we be using? J Thorac Cardiovasc Surg. 2016;152(5):1230–1232.
   PubMed Web of Science ®Google Scholar
• Cavalcanti FPE, Sá MP, Santos CA, et al. Pulmonary valve replacement after operative repair of tetralogy of Fallot: meta-analysis and meta-regression of 3,118 patients from 48 studies. J Am Coll Cardiol. 2013;62(23):2227–2243.
   PubMed Web of Science ®Google Scholar
• Ozkara A, Mert M, Cetin G, et al. Right ventricular outflow tract reconstruction for tetralogy of fallot with abnormal coronary artery: experience with 35 patients. J Card Surg. 2006;21(2):131–136.
   PubMed Web of Science ®Google Scholar
• Dos L, Dadashev A, Tanous D, et al. Pulmonary valve replacement in repaired tetralogy of Fallot: determinants of early postoperative adverse outcomes. J Thorac Cardiovasc Surg. 2009;138(3):553–559.
   PubMed Web of Science ®Google Scholar
• Chen PC, Sager MS, Zurakowski D, et al. Younger age and valve oversizing are predictors of structural valve deterioration after pulmonary valve replacement in patients with tetralogy of Fallot. J Thorac Cardiovasc Surg. 2012;143(2):352–360.
   PubMed Web of Science ®Google Scholar
• Malekzadeh-Milani S, Ladouceur M, Iserin L, et al. Incidence and outcomes of right-sided endocarditis in patients with congenital heart disease after surgical or transcatheter pulmonary valve implantation. J Thorac Cardiovasc Surg. 2014;148(5):2253–2259.
   PubMed Web of Science ®Google Scholar
• Mery CM, Guzmán-Pruneda FA, De León LE, et al. Risk factors for development of endocarditis and reintervention in patients undergoing right ventricle to pulmonary artery valved conduit placement. J Thorac Cardiovasc Surg. 2016;151(2):432–9, 41.e1–2.
   PubMed Web of Science ®Google Scholar
• Miranda WR, Connolly HM, Bonnichsen CR, et al. Prosthetic pulmonary valve and pulmonary conduit endocarditis: clinical, microbiological and echocardiographic features in adults. Eur Heart J Cardiovasc Imaging. 2016;17(8):936–943.
   PubMed Web of Science ®Google Scholar
• Mahesh B, Angelini G, Caputo M, et al. Prosthetic valve endocarditis. Ann Thorac Surg. 2005;80(3):1151–1158.
   PubMed Web of Science ®Google Scholar
• Doughan AR, McConnell ME, Lyle TA, et al. Effects of pulmonary valve replacement on QRS duration and right ventricular cavity size late after repair of right ventricular outflow tract obstruction. Am J Cardiol. 2005;95(12):1511–1514.
   PubMed Web of Science ®Google Scholar
• Lindsey CW, Parks WJ, Kogon BE, et al. Pulmonary valve replacement after tetralogy of Fallot repair in preadolescent patients. Ann Thorac Surg. 2010;89(1):147–151.
   PubMed Web of Science ®Google Scholar
• Magovern GJ, Cromie HW. Sutureless prosthetic heart valves. J Thorac Cardiovasc Surg. 1963;46:726–736.
   PubMed Web of Science ®Google Scholar
• Martínez-Comendador J, Castaño M, Gualis J, et al. Sutureless aortic bioprosthesis. Interact Cardiovasc Thorac Surg. 2017;25(1):114–121.
   PubMed Web of Science ®Google Scholar
• Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Transcatheter implantation of a bovine valve in pulmonary position: a lamb study. Circulation. 2000;102(7):813–816.
   PubMed Web of Science ®Google Scholar
• Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356(9239):1403–1405.
   PubMed Web of Science ®Google Scholar
• Shahanavaz S, McElhinney DB. Transcatheter pulmonary valve replacement: evolving indications and application. Future Cardiol. 2018;14:511–524.
   PubMed Web of Science ®Google Scholar
• Shahanavaz S, Asnes JD, Grohmann J, et al. Intentional fracture of bioprosthetic valve frames in patients undergoing valve-in-valve transcatheter pulmonary valve replacement. Circ Cardiovasc Interv. 2018;11(8):e006453.
   PubMed Web of Science ®Google Scholar
• Cabalka AK, Asnes JD, Balzer DT, et al. Transcatheter pulmonary valve replacement using the melody valve for treatment of dysfunctional surgical bioprostheses: a multicenter study. J Thorac Cardiovasc Surg. 2018;155(4):1712–24.e1.
   PubMed Web of Science ®Google Scholar
• Gillespie MJ, Rome JJ, Levi DS, et al. Melody valve implant within failed bioprosthetic valves in the pulmonary position: a multicenter experience. Circ Cardiovasc Interv. 2012;5(6):862–870.
   PubMed Web of Science ®Google Scholar
• Tretter JT, Friedberg MK, Wald RM, et al. Defining and refining indications for transcatheter pulmonary valve replacement in patients with repaired tetralogy of Fallot: contributions from anatomical and functional imaging. Int J Cardiol. 2016;221:916–925.
   PubMed Web of Science ®Google Scholar
• Morgan GJ, Waragai T, Eastaugh L, et al. The fellows stitch: large caliber venous hemostasis in pediatric practice. Catheter Cardiovasc Interv. 2012;80(1):79–82.
   PubMed Web of Science ®Google Scholar
• Virk SA, Liou K, Chandrakumar D, et al. Percutaneous pulmonary valve implantation: a systematic review of clinical outcomes. Int J Cardiol. 2015;201:487–489.
   PubMed Web of Science ®Google Scholar
• Cheatham JP, Hellenbrand WE, Zahn EM, et al. Clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the US melody valve investigational device exemption trial. Circulation. 2015;131(22):1960–1970.
   PubMed Web of Science ®Google Scholar
• Nordmeyer J, Lurz P, Khambadkone S, et al. Pre-stenting with a bare metal stent before percutaneous pulmonary valve implantation: acute and 1-year outcomes. Heart. 2011;97(2):118–123.
   PubMed Web of Science ®Google Scholar
• Garay F, Webb J, Hijazi ZM. Percutaneous replacement of pulmonary valve using the Edwards-Cribier percutaneous heart valve: first report in a human patient. Catheter Cardiovasc Interv. 2006;67(5):659–662.
   PubMed Web of Science ®Google Scholar
• Kenny D, Hijazi ZM, Kar S, et al. Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial. J Am Coll Cardiol. 2011;58(21):2248–2256.
   PubMed Web of Science ®Google Scholar
• Kenny D, Rhodes JF, Fleming GA, et al. 3-Year outcomes of the Edwards Sapien transcatheter heart valve for conduit failure in the pulmonary position from the compassion multicenter clinical trial. JACC Cardiovasc Interv. 2018;11(19):1920–1929.
   PubMed Web of Science ®Google Scholar
• Morgan GJ, Sadeghi S, Salem MM, et al. SAPIEN valve for percutaneous transcatheter pulmonary valve replacement without “pre-stenting”: a multi-institutional experience. Catheter Cardiovasc Interv. 2019;93(2):324–329.
   PubMed Web of Science ®Google Scholar
• Allen KB, Chhatriwalla AK, Cohen DJ, et al. Bioprosthetic valve fracture to facilitate transcatheter valve-in-valve implantation. Ann Thorac Surg. 2017;104(5):1501–1508.
   PubMed Web of Science ®Google Scholar
• Chhatriwalla AK, Allen KB, Saxon JT, et al. Bioprosthetic valve fracture improves the hemodynamic results of valve-in-valve transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2017;10:7.
   Web of Science ®Google Scholar
• Sinha S, Aboulhosn J, Asnes J, et al. Initial results from the off-label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement: a multi-institutional experience. Catheter Cardiovasc Interv. 2019Feb 15;93(3):455–463.
   Web of Science ®Google Scholar
• Kenny D, Morgan GJ, Murphy M, et al. Use of 65 cm large caliber dryseal sheaths to facilitate delivery of the Edwards Sapien valve to dysfunctional right ventricular outflow tracts. Catheter Cardiovasc Interv. 2019;94:409–413.
   PubMed Web of Science ®Google Scholar
• Spriestersbach H, Prudlo A, Bartosch M, et al. First percutaneous implantation of a completely tissue-engineered self-expanding pulmonary heart valve prosthesis using a newly developed delivery system: a feasibility study in sheep. Cardiovasc Interv Ther. 2017;32(1):36–47.
   PubMed Web of Science ®Google Scholar
• Bergersen L, Benson LN, Gillespie MJ, et al. Harmony feasibility trial: acute and short-term outcomes with a self-expanding transcatheter pulmonary valve. JACC Cardiovasc Interv. 2017;10(17):1763–1773.
   PubMed Web of Science ®Google Scholar